Show Summary Details
Page of

Prion diseases 

Prion diseases
Prion diseases

Simon Mead

, Peter Rudge

, and John Collinge

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 25 July 2021

Prion diseases are fatal and transmissible neurodegenerative disorders of humans and animals. They are caused by the seeded polymerization of host prion protein into a misfolded form. The human conditions include sporadic and variant Creutzfeldt–Jakob disease, inherited and iatrogenic prion diseases. Generally rapidly progressive in clinical course and involving cognitive and neurological domains, diagnosis is often made late although a range of highly sensitive and specific diagnostic tools are available. Diffusion-weighted MRI brain shows characteristic high signal changes in the basal ganglia, cortex, and thalamus. CSF studies show raised neuronal and glial proteins, and a highly specific test based on the in vitro amplification of abnormal prion protein is becoming clinically available. Genetic analysis is typically done even in the absence of a family history as several partially penetrant mutations are recognized. Several symptomatic treatments may be useful. Early involvement of specialist multidisciplinary services and palliative care are recommended.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.